Eni SpA vs 22nd Century Group Inc — how do they compare? Eni SpA trades at $55.38 (market cap $80.32B), while 22nd Century Group Inc trades at $4.46 (market cap $1.52M). The key difference: Eni SpA is far larger — about 52842.1× 22nd Century Group Inc's market cap, and Eni SpA pays a 4.4% dividend while 22nd Century Group Inc pays none. Which is the better fit depends on your goals.
| E | XXII | |
|---|---|---|
Market Cap | $80.32B | $1.52M |
Sector | Energy | Technology |
52-Week High | $57.61 | $801.00 |
52-Week Low | $34.03 | $3.72 |
Enterprise Value | $105.61B | -$6.71M |
Dividend Yield | 4.4% | — |
Signals from Pluang's Aura AI — not financial advice
Eni (E) trades at $54.87, up 2.35% today, with a bullish technical signal from moving averages. The stock shows attractive valuation multiples, including a P/E of 12.5 and P/S of 0.82, while recent earnings have been mixed with Q2 2026 missing estimates despite 21.5% revenue growth. Strong cash flow from operations of $13.33 billion in 2025 supports shareholder returns, including a recently increased share buyback program.
The outlook is cautiously optimistic, with production growth and strategic partnerships offering upside, but commodity price volatility and recent earnings misses present risks. Analyst sentiment is mixed, with a 'Moderate Buy' consensus but a majority of holds, reflecting balanced near-term prospects amid energy market uncertainties.
No Aura AI signal available yet.
Trailing returns across standard periods
Eni is an integrated oil and gas company that explores for, produces, and refines oil around the world. In 2021, the company produced 0.8 million barrels of liquids and 4.6 billion cubic feet of natural gas per day. At end-2021, Eni held reserves of 6.6 billion barrels of oil equivalent, 49% of which are liquids. The Italian government owns a 30.1% stake in the company. Eni is placing its renewable and low-carbon business in a separate entity, Plentitude
Read more on E →22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.
Read more on XXII →